Apothékary
PrivateLast Round
Series A
Extension
Jun 29, 2026
Total Funding Raised
$38M
Company Overview
Apothékary is a wellness company that provides Japanese-inspired plant-based herbal tinctures and supplements as alternatives to over-the-counter drugs and synthetic supplements.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Subscription Commerce, Home & Lifestyle
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apothékary Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Apothékary Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 29, 2026 | ||||
| Series A | Nov 20, 2024 | ||||
| Debt | Mar 14, 2024 | ||||
| Seed | Sep 1, 2022 | ||||
| Seed | Nov 22, 2021 |
Apothékary Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RSF Social Finance | Series A Extension |
| Venrex | Series A, Seed |
| Shiseido | Series A Extension, Series A |
| Trousdale Ventures | Series A, Seed |
| Stella Capital | Series A |
| NextLevel Management | Series A Extension |
| Strand Equity | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Founder Shizu Okusa received the Inc. 500 Female Founder Honoree award.
- Jan 1, 2026
Introduced a 30-day guided program called the 'Break the Stress Cycle Challenge'.
Apothékary Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apothékary's valuation, stock price, and market status.